These data confirm the clinical efficacy of Hepilor® in the treatment of oral mucositis in cancer patients. Together with an adequate oral hygiene, it reduced the severity of oral mucositis and its related symptoms, improving patients' quality of life.
Togni et al. (Sun,) studied this question.